DPP4 and diabetes mellitus: MF also has superiority over other anti-DM medications, such as sulphonylurea, thiazolidinediones, dipeptidyl peptidase 4 (DPP-4) inhibitors, and alpha-glucosidase inhibitors, in term of less hypoglycaemic risk and weight gain [46].